Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Preferred Shares Issued (2020)

Historic Preferred Shares Issued for Immuneering (IMRX) over the last 1 years, with Q4 2020 value amounting to $37.2 million.

  • Immuneering's Preferred Shares Issued changed N/A to $37.2 million in Q4 2020 from the same period last year, while for Dec 2021 it was $37.2 million, marking a year-over-year change of. This contributed to the annual value of $24.8 million for FY2021, which is 3297.4% down from last year.
  • As of Q4 2020, Immuneering's Preferred Shares Issued stood at $37.2 million.
  • In the past 5 years, Immuneering's Preferred Shares Issued ranged from a high of $37.2 million in Q4 2020 and a low of $37.2 million during Q4 2020